Alpha Tau Medical Ltd (DRTS) stock has gained 45.60% over the past 12 months, and the average Wall Street analyst rating is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives the DRTS title a score of 15 out of a possible 100.
This ranking is influenced by a short-term technical score of 0. The DRTS ranking also includes a long-term technical score of 0. The fundamental score for DRTS is 45. In addition to the average Wall Street analyst rating, DRTS stock has an average target price of $18.00. This means that analysts expect the stock to climb 28.11% over the next 12 months.
What’s happening with DRTS Stock today
Alpha Tau Medical Ltd (DRTS) stock gained 19.27% while the S&P 500 gained 0.37% at 9:36 a.m. Thursday, March 24. DRTS gained $2.27 from the previous closing price of $11.78 on volume of 32,534 shares. Over the past year, the S&P 500 has risen 15.01% while DRTS has gained 45.60%. DRTS has earned $0.16 per share over the past 12 months, giving it a price-earnings ratio of 86.45. Click here for the full Alpha Tau Medical Ltd stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.